PAPER Matus S, Glimcher LH, Hetz C
SEARCH RESULTS
330919 RESULTS
PAPER Capell A, Liebscher S, Fellerer K, Brouwers N, Willem M, Lammich S, Gijselinck I, Bittner T, Carlson AM, Sasse F, Kunze B, Steinmetz H, Jansen R, Dormann D, Sleegers K, Cruts M, Herms J, Van Broeckhoven C, Haass C
Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase.
J Neurosci. 2011 Feb 2;31(5):1885-94. PubMed: 21289198PAPER Niu C, Zhang J, Mei J, Fu X
Does neurotrophic factor benefit to PD therapy via co-function with ubiquitin-proteasome system?
Med Hypotheses. 2011 Apr;76(4):589-92. PubMed: 21288653PAPER Miller BA, Zhang W
TRP channels as mediators of oxidative stress.
Adv Exp Med Biol. 2011;704:531-44. PubMed: 21290315PAPER Liu ZB, Niu WM, Yang XH, Wang Y, Wang WG
Study on perfume stimulating olfaction with volatile oil of Acorus gramineus for treatment of the Alzheimer's disease rat.
J Tradit Chin Med. 2010 Dec;30(4):283-7. PubMed: 21287786PAPER Ihl R, Frölich L, Winblad B, Schneider L, Burns A, Möller HJ,
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.
World J Biol Psychiatry. 2011 Feb;12(1):2-32. PubMed: 21288069PAPER Frankola KA, Greig NH, Luo W, Tweedie D
Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.
CNS Neurol Disord Drug Targets. 2011 May;10(3):391-403. PubMed: 21288189PAPER Wollenweber FA, Schomburg R, Probst M, Schneider V, Hiry T, Ochsenfeld A, Mueller M, Dillmann U, Fassbender K, Behnke S
Width of the third ventricle assessed by transcranial sonography can monitor brain atrophy in a time- and cost-effective manner--results from a longitudinal study on 500 subjects.
Psychiatry Res. 2011 Mar 31;191(3):212-6. PubMed: 21288698PAPER Huang KF, Liaw SS, Huang WL, Chia CY, Lo YC, Chen YL, Wang AH
Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.
J Biol Chem. 2011 Apr 8;286(14):12439-49. PubMed: 21288892PAPER Kanekiyo T, Zhang J, Liu Q, Liu CC, Zhang L, Bu G
Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.
J Neurosci. 2011 Feb 2;31(5):1644-51. PubMed: 21289173PAPER Shipton OA, Leitz JR, Dworzak J, Acton CE, Tunbridge EM, Denk F, Dawson HN, Vitek MP, Wade-Martins R, Paulsen O, Vargas-Caballero M
Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation.
J Neurosci. 2011 Feb 2;31(5):1688-92. PubMed: 21289177PAPER Gant JC, Chen KC, Norris CM, Kadish I, Thibault O, Blalock EM, Porter NM, Landfield PW
Disrupting function of FK506-binding protein 1b/12.6 induces the Ca²+-dysregulation aging phenotype in hippocampal neurons.
J Neurosci. 2011 Feb 2;31(5):1693-703. PubMed: 21289178PAPER Tamboli IY, Hampel H, Tien NT, Tolksdorf K, Breiden B, Mathews PM, Saftig P, Sandhoff K, Walter J
Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes Abeta generation.
J Neurosci. 2011 Feb 2;31(5):1837-49. PubMed: 21289194PAPER Han SH, Chang YJ, Jung ES, Kim JW, Na DL, Mook-Jung I
Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles.
Int J Nanomedicine. 2011;6:1-12. PubMed: 21289976PAPER Dasari M, Espargaro A, Sabate R, Lopez Del Amo JM, Fink U, Grelle G, Bieschke J, Ventura S, Reif B
Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Chembiochem. 2011 Feb 11;12(3):407-23. PubMed: 21290543Current Filters
No filters selected